A Diabetes RELIEF Initiative: Realizing the Potential of GLP-1 Receptor Agonists in Type 2 Diabetes: Partnering with Patients to Improve Glycemic and Cardiovascular Outcomes
Released On
May 11, 2023
Expires On
May 11, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Family Practice, Internal Medicine, Primary Care
Topic(s)
T2DM, Diabetes
This activity is provided by Med Learning Group.
This is activity is co-provided by AMEDCO.
This activity is supported by an educational grant from Novo Nordisk, Inc.
Nursing learners, view this Learner Notification prior to starting this activity.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — 1.0 Contact Hours
- AAFP — 1.00 Self-Study AAFP Prescribed credit
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is intended for family practice physicians, internal medicine physicians, nurse practitioners, physician assistants, and other clinicians who provide primary care services as well as patients with T2DM.
Program Overview
The educational activity focuses on the role of GLP-1 receptor agonists in the care of patients with type 2 diabetes, including but not limited to, the glycemic and extra-glycemic effects and strategies to avoid adverse events of GLP-1 receptor agonists while enhancing the patient/provider partnership using a shared decision-making approach to the selection of GLP-1 receptor agonists.
Educational Objectives
Upon the completion of this program, attendees should be able to:
- Evaluate the role of GLP-1 receptor agonists in the care of patients with type 2 diabetes
- Assess the glycemic and extra-glycemic effects of GLP-1 receptor agonists
- Describe strategies for enhancing the patient/provider partnership when managing patients with T2DM
- Implement a shared decision-making approach to the selection of GLP-1 receptor agonists
- Determine strategies for avoiding adverse effects of GLP-1 receptor agonists
Program Chair & Faculty Presenter
Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
Medical Director, AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute
Adjunct Professor of Medicine, John Hopkins University School of Medicine
Orlando, FL
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
AAFP Accreditation
The AAFP has reviewed A Diabetes RELIEF Initiative: Realizing the Potential of GLP-1 Receptor Agonists in Type 2 Diabetes: Partnering with Patients to Improve Glycemic and Cardiovascular Outcomes - Enduring, and deemed it acceptable for AAFP credit. Term of approval is from 04/21/2023 to 04/21/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This session is approved for 1.00 Self-Study AAFP Prescribed credit.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosures of Relevant Financial Relationships
Richard E. Pratley, MD, reports that he has served on an advisory board and/or as a consultant for Bayer AG, Gasherbrum Bio, Hengrui (USA) Ltd., Merck, Novo Nordisk, Rivus Pharmaceuticals, and Sun Pharmaceutical Industries. He has also been a speaker for Merck and Novo Nordisk, and has provided contract research support for Novo Nordisk. Dr. Pratley has served on the American Diabetes Association Professional Practice Committee and Precision Medicine Committee. All honoraria are directed toward a non-profit that supports education and research.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer-reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Sylvia Hanna, MD, Medical Director for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.
Lauren Bartunek, Program Manager for Med Learning Group, has nothing to disclose.
Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose
Method of Participation
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Complete the post-test and evaluation.
You will receive your certificate as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/"
Americans with Disabilities Act
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com.
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
